INTEGER HOLDINGS CORPORATION Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
INTEGER HOLDINGS CORPORATION (ITGR) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $45.13 per share for the 12-month period ending 2018-12-28, per its 10-K filed 2019-02-22.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2019-02-22
- INTEGER HOLDINGS CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2018-03-30 was $45.13, a 52.72% increase year-over-year.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2017-03-31 was $29.55, a 43.09% decline year-over-year.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2016-04-01 was $51.92.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2018 was $45.13, a 16.37% increase from fiscal 2017.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2017 was $38.78, a 9.43% decline from fiscal 2016.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2016 was $42.82.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2018-12-28 | $45.13 10-K · filed 2019-02-22 | |||
| 2018-09-28 | $45.13 10-Q · filed 2018-11-02 | |||
| 2018-06-29 | $45.13 10-Q · filed 2018-08-03 | |||
| 2018-03-30 | $45.13 10-Q · filed 2018-05-04 | |||
| 2017-12-29 | $38.78 10-K · filed 2018-02-22 | |||
| 2017-09-29 | $38.78 10-Q · filed 2017-10-30 | |||
| 2017-06-30 | $32.99 10-Q · filed 2017-08-02 | |||
| 2017-03-31 | $29.55 10-Q · filed 2017-05-09 | |||
| 2016-12-30 | $42.82 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $49.58 10-Q · filed 2016-11-08 | |||
| 2016-07-01 | $50.69 10-Q · filed 2016-08-09 | |||
| 2016-04-01 | $51.92 10-Q · filed 2016-05-10 | |||
| 2015-10-02 | $49.20 10-Q · filed 2015-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |